
JSI Preparedness Assessment for Pneumococcal Conjugate Vaccine Introduction in India: A Novel Approach
Published on August 12, 2024
Checkout this article which discusses the innovative approach taken by JSI India to assess preparedness for introducing the pneumococcal conjugate vaccine (PCV) in India. Faced with the challenges of the COVID-19 pandemic, JSI developed the PCV Roll Out Monitoring and Preparedness Tool (PROMPT), a digital platform that streamlined data collection, assessment, and decision-making processes. PROMPT's success in facilitating timely assessments across all states highlights the effectiveness of digital solutions in overcoming healthcare challenges and ensuring resilient immunization systems. To read more, click the link below!
